Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
This study will examine the efficacy and safety of HLD200 (methylphenidate) in patients age 6-12 years with ADHD. This study has a 6-week dose optimization period followed by a one week double blind randomization assessment.
Inclusion criteria
- Attention Deficit Hyperactivity Disorder